Ömer An

1.9k total citations
30 papers, 740 citations indexed

About

Ömer An is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Ömer An has authored 30 papers receiving a total of 740 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 6 papers in Cancer Research and 4 papers in Genetics. Recurrent topics in Ömer An's work include RNA Research and Splicing (12 papers), RNA regulation and disease (11 papers) and RNA modifications and cancer (8 papers). Ömer An is often cited by papers focused on RNA Research and Splicing (12 papers), RNA regulation and disease (11 papers) and RNA modifications and cancer (8 papers). Ömer An collaborates with scholars based in Singapore, United Kingdom and United States. Ömer An's co-authors include Henry Yang, Francesca D. Ciccarelli, Leilei Chen, Giovanni Marco Dall’Olio, Yangyang Song, Thanos P. Mourikis, Vanessa Hui En Ng, Daryl Jin Tai Tay, Sze Jing Tang and Jian Han and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and Blood.

In The Last Decade

Ömer An

29 papers receiving 735 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ömer An Singapore 16 628 210 61 61 55 30 740
Jingnan Sun China 10 404 0.6× 238 1.1× 59 1.0× 94 1.5× 44 0.8× 21 506
Guangshuai Jia China 6 387 0.6× 98 0.5× 108 1.8× 93 1.5× 113 2.1× 8 520
Susana Kofman Mexico 12 270 0.4× 99 0.5× 53 0.9× 57 0.9× 22 0.4× 23 431
Angelique Lin United States 5 331 0.5× 77 0.4× 70 1.1× 111 1.8× 60 1.1× 6 418
Thilini R. Fernando United States 10 422 0.7× 376 1.8× 56 0.9× 41 0.7× 85 1.5× 12 565
Katarzyna Smigielska‐Czepiel Netherlands 8 309 0.5× 316 1.5× 45 0.7× 19 0.3× 148 2.7× 8 494
Gergely Buglyó Hungary 10 287 0.5× 209 1.0× 55 0.9× 16 0.3× 28 0.5× 19 463
Madeleine Poirier Canada 6 241 0.4× 131 0.6× 74 1.2× 15 0.2× 30 0.5× 7 454
Kayla McEnery United States 8 233 0.4× 133 0.6× 75 1.2× 15 0.2× 79 1.4× 9 401

Countries citing papers authored by Ömer An

Since Specialization
Citations

This map shows the geographic impact of Ömer An's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ömer An with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ömer An more than expected).

Fields of papers citing papers by Ömer An

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ömer An. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ömer An. The network helps show where Ömer An may publish in the future.

Co-authorship network of co-authors of Ömer An

This figure shows the co-authorship network connecting the top 25 collaborators of Ömer An. A scholar is included among the top collaborators of Ömer An based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ömer An. Ömer An is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nga, Min En, Yee Kit Tai, Hung Chew Wong, et al.. (2024). Impact of CD151 overexpression on prognosis and therapy in non‐small cell lung cancer patients lacking EGFR mutations. Cell Proliferation. 57(9). e13708–e13708. 4 indexed citations
2.
Gan, Wei Liang, Xi Ren, Vanessa Hui En Ng, et al.. (2024). Hepatocyte-macrophage crosstalk via the PGRN-EGFR axis modulates ADAR1-mediated immunity in the liver. Cell Reports. 43(7). 114400–114400. 9 indexed citations
3.
Liew, Lee Chuen, Ömer An, Beatrice Xuan Ho, et al.. (2023). JAK2 as a surface marker for enrichment of human pluripotent stem cells-derived ventricular cardiomyocytes. Stem Cell Research & Therapy. 14(1). 367–367. 4 indexed citations
4.
5.
Mel, Sanjay De, Nurulhuda Mustafa, Viknesvaran Selvarajan, et al.. (2022). T and NK cell lymphoma cell lines do not rely on ZAP-70 for survival. PLoS ONE. 17(1). e0261469–e0261469.
6.
Shen, Haoqing, Ömer An, Xi Ren, et al.. (2022). ADARs act as potent regulators of circular transcriptome in cancer. Nature Communications. 13(1). 1508–1508. 50 indexed citations
7.
Ho, Beatrice Xuan, Jeremy Kah Sheng Pang, Ying Chen, et al.. (2022). Robust generation of human-chambered cardiac organoids from pluripotent stem cells for improved modelling of cardiovascular diseases. Stem Cell Research & Therapy. 13(1). 529–529. 21 indexed citations
8.
Han, Jian, Ömer An, Xi Ren, et al.. (2022). Multilayered control of splicing regulatory networks by DAP3 leads to widespread alternative splicing changes in cancer. Nature Communications. 13(1). 1793–1793. 15 indexed citations
9.
10.
An, Ömer, Yangyang Song, Xinyu Ke, et al.. (2021). “3G” Trial: An RNA Editing Signature to Guide Gastric Cancer Chemotherapy. Cancer Research. 81(10). 2788–2798. 13 indexed citations
11.
Ho, Beatrice Xuan, Hongbing Yu, Jeremy Kah Sheng Pang, et al.. (2021). Upregulation of the JAK-STAT pathway promotes maturation of human embryonic stem cell-derived cardiomyocytes. Stem Cell Reports. 16(12). 2928–2941. 3 indexed citations
12.
Tang, Sze Jing, Haoqing Shen, Ömer An, et al.. (2020). Cis- and trans-regulations of pre-mRNA splicing by RNA editing enzymes influence cancer development. Nature Communications. 11(1). 799–799. 78 indexed citations
13.
Song, Yangyang, Ömer An, Xi Ren, et al.. (2020). RNA editing mediates the functional switch of COPA in a novel mechanism of hepatocarcinogenesis. Journal of Hepatology. 74(1). 135–147. 44 indexed citations
14.
Song, Yangyang, Ömer An, Xi Ren, et al.. (2020). RNA editing mediates the functional switch of COPA in a novel mechanism of hepatocarcinogenesis. 1 indexed citations
15.
Tan, Shi Hao, Wei Zhong Leong, Phuong Cao Thi Ngoc, et al.. (2019). The enhancer RNA ARIEL activates the oncogenic transcriptional program in T-cell acute lymphoblastic leukemia. Blood. 134(3). 239–251. 54 indexed citations
16.
Shyamsunder, Pavithra, Anand Mayakonda, Pushkar Dakle, et al.. (2019). Identification of a novel enhancer of CEBPE essential for granulocytic differentiation. Blood. 133(23). 2507–2517. 31 indexed citations
17.
Pek, Nicole Min Qian, Beatrice Xuan Ho, Jeremy Kah Sheng Pang, et al.. (2019). Mitochondrial 3243A > G mutation confers pro-atherogenic and pro-inflammatory properties in MELAS iPS derived endothelial cells. Cell Death and Disease. 10(11). 802–802. 28 indexed citations
18.
Teoh, Phaik Ju, Tae‐Hoon Chung, Ömer An, et al.. (2019). Synthetic lethality in multiple myeloma harboring double oncogenic hits of 17p13(del) and 1q21(amp). Clinical Lymphoma Myeloma & Leukemia. 19(10). e50–e51. 1 indexed citations
19.
Teoh, Phaik Ju, Ömer An, Tae‐Hoon Chung, et al.. (2019). ABERRANT HYPEREDITING OF MYELOMA TRANSCRIPTOME BY ADAR1 CONFERS ONCOGENICITY AND IS A MARKER OF POOR PROGNOSIS. Hematological Oncology. 37(S2). 549–549. 3 indexed citations
20.
An, Ömer, Giovanni Marco Dall’Olio, Thanos P. Mourikis, & Francesca D. Ciccarelli. (2015). NCG 5.0: updates of a manually curated repository of cancer genes and associated properties from cancer mutational screenings. Nucleic Acids Research. 44(D1). D992–D999. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jingnan Sun Breakdown of academic impact, for papers by Guangshuai Jia Breakdown of academic impact, for papers by Susana Kofman Breakdown of academic impact, for papers by Angelique Lin Breakdown of academic impact, for papers by Thilini R. Fernando Breakdown of academic impact, for papers by Katarzyna Smigielska‐Czepiel Breakdown of academic impact, for papers by Gergely Buglyó Breakdown of academic impact, for papers by Madeleine Poirier Breakdown of academic impact, for papers by Kayla McEnery
Rankless by CCL
2026